BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18495890)

  • 1. CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage.
    Gonzalez YR; Zhang Y; Behzadpoor D; Cregan S; Bamforth S; Slack RS; Park DS
    J Neurosci; 2008 May; 28(21):5559-69. PubMed ID: 18495890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
    Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J
    Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-gamma requires a novel essential cofactor LMO4.
    Schock SC; Xu J; Duquette PM; Qin Z; Lewandowski AJ; Rai PS; Thompson CS; Seifert EL; Harper ME; Chen HH
    J Neurosci; 2008 Nov; 28(47):12433-44. PubMed ID: 19020036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pim-1 kinase as activator of the cell cycle pathway in neuronal death induced by DNA damage.
    Zhang Y; Parsanejad M; Huang E; Qu D; Aleyasin H; Rousseaux MW; Gonzalez YR; Cregan SP; Slack RS; Park DS
    J Neurochem; 2010 Jan; 112(2):497-510. PubMed ID: 19895669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.
    Park DS; Morris EJ; Bremner R; Keramaris E; Padmanabhan J; Rosenbaum M; Shelanski ML; Geller HM; Greene LA
    J Neurosci; 2000 May; 20(9):3104-14. PubMed ID: 10777774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator.
    Tien ES; Davis JW; Vanden Heuvel JP
    J Biol Chem; 2004 Jun; 279(23):24053-63. PubMed ID: 15051727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage.
    Aleyasin H; Cregan SP; Iyirhiaro G; O'Hare MJ; Callaghan SM; Slack RS; Park DS
    J Neurosci; 2004 Mar; 24(12):2963-73. PubMed ID: 15044535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pro-death role of Cited2 in stroke is regulated by E2F1/4 transcription factors.
    Huang T; González YR; Qu D; Huang E; Safarpour F; Wang E; Joselin A; Im DS; Callaghan SM; Boonying W; Julian L; Dunwoodie SL; Slack RS; Park DS
    J Biol Chem; 2019 May; 294(21):8617-8629. PubMed ID: 30967472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage.
    Morris EJ; Keramaris E; Rideout HJ; Slack RS; Dyson NJ; Stefanis L; Park DS
    J Neurosci; 2001 Jul; 21(14):5017-26. PubMed ID: 11438577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-γ function.
    Liu ZJ; Liu HQ; Xiao C; Fan HZ; Huang Q; Liu YH; Wang Y
    J Neurosci Res; 2014 Nov; 92(11):1549-59. PubMed ID: 24975470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CITED2 Restrains Proinflammatory Macrophage Activation and Response.
    Kim GD; Das R; Rao X; Zhong J; Deiuliis JA; Ramirez-Bergeron DL; Rajagopalan S; Mahabeleshwar GH
    Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons.
    Stefanis L; Park DS; Friedman WJ; Greene LA
    J Neurosci; 1999 Aug; 19(15):6235-47. PubMed ID: 10414953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
    Helguera P; Pelsman A; Pigino G; Wolvetang E; Head E; Busciglio J
    J Neurosci; 2005 Mar; 25(9):2295-303. PubMed ID: 15745955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the intrinsic apoptosis pathway by synaptic activity.
    Léveillé F; Papadia S; Fricker M; Bell KF; Soriano FX; Martel MA; Puddifoot C; Habel M; Wyllie DJ; Ikonomidou C; Tolkovsky AM; Hardingham GE
    J Neurosci; 2010 Feb; 30(7):2623-35. PubMed ID: 20164347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
    Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
    Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
    Liu YC; Chang PY; Chao CC
    Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Cited2 affects trophoblast formation and vascularization of the mouse placenta.
    Withington SL; Scott AN; Saunders DN; Lopes Floro K; Preis JI; Michalicek J; Maclean K; Sparrow DB; Barbera JP; Dunwoodie SL
    Dev Biol; 2006 Jun; 294(1):67-82. PubMed ID: 16579983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells.
    Lau WM; Doucet M; Huang D; Weber KL; Kominsky SL
    Biochem Biophys Res Commun; 2013 Jul; 437(2):261-6. PubMed ID: 23811274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor Vezf1 represses the expression of the antiangiogenic factor Cited2 in endothelial cells.
    AlAbdi L; He M; Yang Q; Norvil AB; Gowher H
    J Biol Chem; 2018 Jul; 293(28):11109-11118. PubMed ID: 29794136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease.
    Ferraz-de-Souza B; Martin F; Mallet D; Hudson-Davies RE; Cogram P; Lin L; Gerrelli D; Beuschlein F; Morel Y; Huebner A; Achermann JC
    J Clin Endocrinol Metab; 2009 Feb; 94(2):678-83. PubMed ID: 18984668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.